RS Research

Private

TurkeyHealthcare & Life Scienceshttps://rsresearch.net/

Last Round

Series A

Dec 15, 2021

Total Funding Raised

$14.16M

Company Overview

RS Research is a drug discovery company that develops targeted oncology therapies using its proprietary drug-delivery platforms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

drug delivery platformpolymer-drug conjugatesnanomedicinetargeted chemotherapyoncology therapiesclinical-stage biotechdrug candidate pipelinetheranosticsPDCsolid tumor treatmentGMP manufacturingpreclinical servicesradioligand therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RS Research Comps

Public and private peers based on sector, stage, and business model.

RS Research comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

RS Research Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Dec 15, 2021
Seed	Apr 21, 2017

View all Funding Rounds

Key People

Founding team and executive leadership

Sena Nomak

Co-Founder COO

Founding Team

RS Research Investors

Notable investors and investment history

RS Research investors
Investor	Rounds
Eczacıbaşı Momentum	Series A
ACT Venture Partners	Series A, Seed
İstanbul Portföy Yönetimi	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 1, 2025
Monthly visitors grew 159% MoM, from 285 to 739.
Feb 17, 2024
Grew 28% QoQ, from 18 to 23 employees.

View all signals

RS Research Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

RS Research Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RS Research's valuation, stock price, and market status.

Firmographic Details

HeadquartersTurkey

Employee Range29

Year Founded2015

Last FundingDec 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.